Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries said Sunday that it will hold its ordinary general meeting (OGM) to discuss the estimated budget for fiscal year 2017/2018 on 28 March.
Furthermore, the OGM will discuss the investment budget set for the new fiscal year, a bourse statement said.
The company targets a net profit before tax of EGP 32 million in FY17/18, with an increase of 3.2% compared to a profit worth EGP 31 million for FY16/17.
Nile Pharmaceuticals eyes EGP 570 million revenues for the next fiscal year, 37.3% up from EGP 415 million for FY16/17.
